Clinical trial
Comparison of Conventional Platelet-Rich Plasma Treatment of Osteoarthritic Knee With a New Autologous Blood Product (CytoRich)
NCT03543800 is registered in ClinicalTrials.gov with Antnor as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Conventional Platelet-Rich Plasma Treatment of Osteoarthritic Knee With a New Autologous Blood Product (CytoRich)
- Lead sponsor
- Antnor
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 4, 2015
- Completion date
- May 20, 2019
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
osteoarthritis of the knee